PubMed=14687616; DOI=10.1016/j.leukres.2003.08.014
Wong K.-F.
A novel EBV-negative natural killer cell line.
Leuk. Res. 28:225-227(2004)

PubMed=14687623; DOI=10.1016/S0145-2126(03)00254-6
Chen I.-M., Whalen M., Bankhurst A.D., Sever C.E., Doshi R., Hardekopf D., Montgomery K.D., Willman C.L.
A new human natural killer leukemia cell line, IMC-1. A complex chromosomal rearrangement defined by spectral karyotyping: functional and cytogenetic characterization.
Leuk. Res. 28:275-284(2004)

PubMed=21052088; DOI=10.1038/leu.2010.255
Iqbal J., Weisenburger D.D., Chowdhury A., Tsai M.-Y., Srivastava G., Greiner T.C., Kucuk C., Deffenbacher K.E., Vose J.M., Smith L., Au W.Y., Nakamura S., Seto M., Delabie J., Berger F., Loong F., Ko Y.-H., Sng I., Liu X., Loughran T.P. Jr., Armitage J.O., Chan W.-C.
International Peripheral T-cell Lymphoma Project
Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic gammadelta T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro.
Leukemia 25:348-358(2011)